Fatty acid synthase expression in cutaneous melanocytic neoplasms

Modern Pathology

Volumn 18, Issue 8, 2005, Pages 1107-1112

  Kapur, Payal ^a   Rakheja, Dinesh ^a,b   Roy, Lonnie C ^b   Hoang, Mai P ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b CHILDREN S MEDICAL CENTER   (United States)

Author keywords

Congenital melanocytic nevi; Fatty acid synthase; Immunohistochemistry; Malignant melanoma; Melanocytic nevi; Spitz nevi

Indexed keywords

FATTY ACID SYNTHASE; FATTY ACID SYNTHASE INHIBITOR;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; COLON CARCINOMA; CONGENITAL NEVUS; ENDOMETRIUM CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JUVENILE MELANOMA; MAJOR CLINICAL STUDY; MELANOCYTIC NEVUS; MELANOMA; METASTASIS; OVARY CARCINOMA; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN EXPRESSION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FATTY ACID SYNTHETASE COMPLEX; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; MIDDLE AGED; NEOPLASM METASTASIS; NEVUS; NEVUS, EPITHELIOID AND SPINDLE CELL; NEVUS, PIGMENTED; SKIN NEOPLASMS;

EID: 24044480642     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3800395     Document Type: Article

References (26)

1. Kusakabe T, Maeda M, Hoshi N, et al. Fatty acid synthase is expressed mainly in adult hormone-sensitive cells or cells with high lipid metabolism and in proliferating fetal cells. J Histochem Cytochem 2000;48:613-622.
2. Alo PL, Visca P, Trombetta G, et al. Fatty acid synthase (FAS) predictive strength in poorly differentiated early breast carcinomas. Tumori 1999;85:35-40.
3. Shurbaji MS, Kalbfleisch JH, Thurmond TS. Immunohistochemical detection of a fatty acid synthase (OA-519) as a predictor of progression of prostate cancer. Hum Pathol 1996;27:917-921.
4. Rashid A, Pizer ES, Moga M, et al. Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal neoplasia. Am J Pathol 1997;150:201-208.
5. Gansler TS, Hardman III W, Hunt DA, et al. Increased expression of fatty acid synthase (OA-519) in ovarian neoplasms predicts shorter survival. Hum Pathol 1997;28:686-692.
6. Kusakabe T, Nashimoto A, Honma K, et al. Fatty acid synthase is highly expressed in carcinoma, adenoma and in regenerative epithelium and intestinal metaplasia of the stomach. Histopathology 2002;40:71-79.
7. Nemoto T, Terashima S, Kogure M, et al. Overexpression of fatty acid synthase in oesophageal squamous cell dysplasia and carcinoma. Pathobiology 2001;69:297-303.
8. Piyathilake CJ, Frost AR, Manne U, et al. The expression of fatty acid synthase (FASE) is an early event in the development and progression of squamous cell carcinoma of the lung. Hum Pathol 2000;31:1068-1073.
9. Krontiras H, Roye GD, Beenken SE, et al. Fatty acid synthase expression is increased in neoplastic lesions of the oral tongue. Head Neck 1999;21:325-329.
10. Sekiguchi M, Shiroko Y, Arai T, et al. Biological characteristics and chemosensitivity profile of four human anaplastic thyroid carcinoma cell lines. Biomed Pharmacother 2001;55:466-474.
11. Gabrielson EW, Finn ML, Testa JR, et al. Increased fatty acid synthase is a therapeutic target in mesothelioma. Clin Cancer Res 2001;7:153-157.
12. Pizer ES, Lax SF, Kuhajda FP, et al. Fatty acid synthase expression in endometrial carcinoma: correlation with cell proliferation and hormone receptors. Cancer 1998;83:528-537.
13. Innocenzi D, Alo PL, Balzani A, et al. Fatty acid synthase expression in melanoma. J Cutan Pathol 2003;30:23-28.
14. Kuhajda FP, Jenner K, Wood FD, et al. Fatty acid synthesis: a potential selective target for antineoplastic therapy. Proc Natl Acad Sci USA 1994;91:6379-6383.
15. Liu B, Wang Y, Fillgrove KL, et al. Triclosan inhibits enol-reductase of type I fatty acid synthase in vitro and is cytotoxic to MCF-7 and SKBr-3 breast cancer cells. Cancer Chemother Pharmacol 2002;49:187-193.
16. Kapur P, Selim MA, Roy LC, et al. Spitz nevi and atypical Spitz nevi/tumors: a histologic and immunohistochemical analysis. Mod Pathol 2004;18:197-204.
17. Kamino H, Tam ST. Immunoperoxidase technique modified by counterstain with azure B as a diagnostic aid in evaluating heavily pigmented melanocytic neoplasms. J Cutan Pathol 1991;18:436-439.
18. Uchiyama N, Yamamoto A, Kameda K, et al. The activity of fatty acid synthase of epidermal keratinocytes is regulated in the lower stratum spinulosum and the stratum basale by local inflammation rather than by circulating hormones. J Dermatol Sci 2000;24:134-141.
19. Jayakumar A, Chirala SS, Chinault AC, et al. Isolation and chromosomal mapping of genomic clones encoding the human fatty acid synthase gene. Genomics 1994;23:420-424.
20. Pizer ES, Chrest FJ, DiGiuseppe JA, et al. Pharmacological inhibitors of mammalian fatty acid synthase suppress DNA replication and induce apoptosis in tumor cell lines. Cancer Res 1998;58:4611-4615.
21. Kuhajda FP. Fatty acid synthase and human cancer: new perspectives on its role in tumor biology. Nutrition 2000;16:202-208.
22. Alper JC, Holmes LB. The incidence and significance of birthmarks in a cohort of 4,641 newborns. Pediatr Dermatol 1983;1:58-68.
23. Walton RG, Jacobs AH, Cox AJ. Pigmented lesions in newborn infants. Br J Dermatol 1976;95:389-396.
24. Kopf AW, Bart RS, Hennessey P. Congenital nevocytic nevi and malignant melanomas. J Am Acad Dermatol 1979;1:123-130.
25. Berg P, Lindelof B. Congenital melanocytic nevi and cutaneous melanoma. Melanoma Res 2003;13:441-445.
26. Bittencourt FV, Marghoob AA, Kopf AW, et al. Large congenital melanocytic nevi and the risk for development of malignant melanoma and neurocutaneous melanocytosis. Pediatrics 2000;106:736-741.